Skip to content

Value of serum CA125 levels in the assessment of volume burden in patients with nephrotic syndrome and chronic kidney disease

Value of serum CA125 levels in the assessment of volume burden in patients with nephrotic syndrome and chronic kidney disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074576
Enrollment
Unknown
Registered
2023-08-10
Start date
2023-08-11
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Patients with nephrotic syndrome and chronic kidney disease:none

Sponsors

Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Clinically diagnosed chronic kidney disease; (2) No peritonitis and acute infection of other sites in the past 1 month; (3) No active liver disease, malignant tumor, benign tumor of the reproductive system, pelvic inflammatory disease and other diseases that affect the measurement index; (4) 18-80 years old, with complete clinical data and informed consent to this study.

Exclusion criteria

Exclusion criteria: Patients with artificial pacemakers or defibrillators inserted; (2) In amputee patients, there are obvious differences in local water distribution, such as deep vein thrombosis of the lower limbs; (3) Patients with mental abnormalities or other reasons who cannot cooperate with this study; (4) Tuberculous pleurisy, peritonitis, malignant chest ascites or liver cirrhosis decompensated ascites patients; (5) According to the judgment of the researcher, there are other circumstances that are not suitable for enrollment.

Design outcomes

Secondary

MeasureTime frame
Blood routine;Urinalysis;Anamnesis;Drug history;BMI;

Primary

MeasureTime frame
CA125;over hydration, OH;BNP;Inferior vena cava variability;Lung B line;Complete biochemical set;24h urine protein quantification;TBW;ECW;ICW;

Countries

CHINA

Contacts

Public ContactFurong Guo

Department of Nephrology, Second Affiliated Hospital of Xi'an Jiaotong University

1697902835@qq.com+86 173 5282 6133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026